PI
KYNB

Putnam Investments’s Kyntra Bio KYNB Stock Holding History

Putnam Investments’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-3,694
Closed -$249K – 1166
2023
Q2 		$249K Sell
3,694
-116
-3% -$48K ﹤0.01% 1111
2023
Q1 		$1.78M Sell
3,810
-809
-18% -$428K ﹤0.01% 754
2022
Q4 		$1.85M Sell
4,619
-3
-0.1% -$1.15K ﹤0.01% 742
2022
Q3 		$1.5M Sell
4,622
-84
-2% -$27.1K ﹤0.01% 791
2022
Q2 		$1.24M Sell
4,706
-58
-1% -$14.8K ﹤0.01% 827
2022
Q1 		$1.43M Sell
4,764
-201
-4% -$70.1K ﹤0.01% 854
2021
Q4 		$1.75M Buy
+4,965
New +$1.55M ﹤0.01% 785
2020
Q4 		– Sell
-2,611
Closed -$2.68M – 811
2020
Q3 		$2.68M Buy
+2,611
New +$2.81M 0.01% 586

Other funds holding KYNB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Putnam Investments's KYNB Position: Q3 2023 in Review

Putnam Investments sold out of Kyntra Bio (KYNB) in Q3 2023, closing a stake of 3,694 shares — an estimated $249K sold.

Putnam Investments first reported a position in KYNB in Q3 2020 and held it in 8 quarters. The position peaked at $2.68M in Q3 2020. 110 funds tracked by Wall St. Rank hold KYNB as of Q3 2023.

  • Putnam Investments reported no remaining Kyntra Bio position as of Q3 2023 after selling out during the quarter.
  • Putnam Investments sold 3,694 Kyntra Bio shares in Q3 2023, an estimated $249K.
  • Putnam Investments first reported a position in Kyntra Bio in Q3 2020 and held it in 8 quarters.
  • Putnam Investments's Kyntra Bio position peaked at $2.68M in Q3 2020.
  • 110 funds tracked by Wall St. Rank held Kyntra Bio as of Q3 2023.

Based on Putnam Investments's 13F filing for Q3 2023, filed 14 Nov 2023.